New-onset diabetes mellitus associated with quetiapine [4]

Canadian Journal of Psychiatry

Volumn 45, Issue 7, 2000, Pages 668-669

  Procyshyn, Ric M ^a   Pande, Suniti ^a   Tse, Gordon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CLONAZEPAM; CLOZAPINE; FLUPHENAZINE; GLUCOSE; INSULIN; LAMOTRIGINE; LOXAPINE; QUETIAPINE; VALPROATE SEMISODIUM; VENLAFAXINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; LETTER; MALE; NAUSEA; POLYDIPSIA; POLYURIA; SCHIZOIDISM; TREATMENT OUTCOME; VOMITING;

ADULT; ANTIPSYCHOTIC AGENTS; DIABETES MELLITUS, TYPE 2; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; PSYCHOTIC DISORDERS;

EID: 0033769308     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Seroquel: Biochemical profile of a potential atypical antipsychotic in late stage development
2. Severe hyperglycemia associated with high doses of clozapine
3. Diabetic ketoacidosis associated with clozapine treatment
4. Ketoacidosis as a side-effect of clozapine: A case report
5. Diabetic ketoacidosis from clozapine and lithium cotreatment
6. Lactic acisodis and fatal myocardial failure due to clozapine
7. Clozapine and associated diabetes mellitus
8. Novel antipsychotics and new onset diabetes
9. New-onset diabetes mellitus associated with the initiation of quetiapine treatment
10. New-onset diabetes melitus and diabetic ketoacidosis associated with olanzapine treatment